← Back to Search

Body Positioning for Premature Birth

N/A
Recruiting
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Viable infants born at ≤32 weeks of gestation on non-invasive NAVA.
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from enrollment in study to end of study (a total of twelve hours)
Awards & highlights

Study Summary

This trial is studying how body position affects a baby's breathing, oxygen, carbon dioxide, lung volume, and more.

Who is the study for?
This trial is for premature infants born at or before 32 weeks of gestation who are stable on non-invasive NAVA ventilation for over 24 hours. It's not suitable for babies with conditions like persistent pulmonary hypertension, contraindications to NAVA, esophageal issues, or congenital heart disease.Check my eligibility
What is being tested?
The study examines the effects of prone (lying face down) versus supine (lying on the back) body positions in premature infants using non-invasive NAVA. Researchers will assess breathing effort, oxygen and carbon dioxide levels, lung volume and compliance, and frequency of events like apnea.See study design
What are the potential side effects?
Since this trial involves body positioning rather than medication, there aren't typical drug side effects. However, changes in position could potentially affect an infant's breathing patterns or stability.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My baby was born at or before 32 weeks and is on a non-invasive breathing support.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from enrollment in study to end of study (a total of twelve hours)
This trial's timeline: 3 weeks for screening, Varies for treatment, and from enrollment in study to end of study (a total of twelve hours) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Minimum electrical activity of the diaphragm (Edi mins)
Number of apenic events
Number of bradycardia events
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Prone positioningExperimental Treatment1 Intervention
Group II: Supine positioningActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
495 Previous Clinical Trials
2,798,844 Total Patients Enrolled
Kristin Glass, MDStudy DirectorPenn State College of Medicine

Media Library

Prone positioning Clinical Trial Eligibility Overview. Trial Name: NCT05968586 — N/A
Ventilator Lung Research Study Groups: Prone positioning, Supine positioning
Ventilator Lung Clinical Trial 2023: Prone positioning Highlights & Side Effects. Trial Name: NCT05968586 — N/A
Prone positioning 2023 Treatment Timeline for Medical Study. Trial Name: NCT05968586 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the criteria for enrolment in this clinical trial include those aged 65 or older?

"Prospective participants of this trial must be of age between 1 Minute and 3 Months."

Answered by AI

Is there a possibility for me to join this experiment?

"To partake in this investigation, participants must have ventilator lung and fit within the age bracket of 1 Minute to 3 Months. A total of 30 individuals are needed for inclusion into the trial."

Answered by AI

Are there any vacancies for participants in this experiment?

"As seen on the clinicaltrials.gov website, this medical study is no longer actively recruiting participants - it was first posted in September of 2023 and last updated in July of that same year. Nevertheless, 303 other trials are still accepting patients at this time."

Answered by AI
~11 spots leftby Sep 2024